Evidence map›Paper›PMID 38850110›Full record

ArticleBiomolecules & biomedicine2024

Impact of

Miroslav Obrenović, Gordana Šupić, Satoru Miyabe, Irena Mladenović, Ružica Kozomara, Saša Jović, Aleksandra Petković Ćurčin, Debora Štefik, Srboljub Stosić, Biserka Vukomanović Đurđević

Abstract read
In one paragraph

Article in Biomolecules & biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miroslav ObrenovićFaculty of Medicine, University of East Sarajevo, Foča, Bosnia and Herzegovina; Department for ENT and Maxillofacial Surgery, University Hospital Foča, Foča, Bosnia and Herzegovina.
Gordana ŠupićMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbia; Institute for Medical Research, Military Medical Academy, Belgrade, Serbia.
Satoru MiyabeDepartment of Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Irena MladenovićFaculty of Medicine, University of East Sarajevo, Foča, Bosnia and Herzegovina; Department of Prosthodontics, University of East Sarajevo, Foča, Bosnia and Herzegovina.
Ružica KozomaraMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbia; Clinic for Maxillofacial Surgery, Military Medical Academy, Belgrade, Serbia.
Saša JovićMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbia; Clinic for Maxillofacial Surgery, Military Medical Academy, Belgrade, Serbia.
Aleksandra Petković ĆurčinMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbia; Institute for Medical Research, Military Medical Academy, Belgrade, Serbia.
Debora ŠtefikInstitute for Medical Research, Military Medical Academy, Belgrade, Serbia.
Srboljub StosićMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbia; Clinic for Maxillofacial Surgery, Military Medical Academy, Belgrade, Serbia.
Biserka Vukomanović ĐurđevićMedical Faculty of Military Medical Academy, University of Defence, Belgrade, Serbiać; Institute for Pathology and Forensic Medicine, Military Medical Academy, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant efforts in developing new diagnostic and therapeutic modalities, oral squamous cell carcinomas (OSCCs) still exhibit a high recurrence rate, a low five-year survival rate, and an increasing prevalence. Toll-like receptors (TLRs), which initiate and perpetuate immune mechanisms upon activation, have been linked to immune surveillance and the antitumor immune response. The aim of this study was to investigate the association between the polymorphisms of the TLR7 rs3853839 and TLR9 rs187084 genes and OSCC risk, clinicopathological features, and survival. Genotyping was assessed by real-time polymerase chain reaction (PCR) in 95 HPV negative OSCC patients and 107 age- and sex-matched healthy controls. Patients with lymph node metastases had higher frequencies of the TLR9 rs187084 CC variant genotype compared to the major TT genotype (P = 0.020) and to T-allele carriers (combined TT + CT genotypes, P = 0.015). A higher prevalence of advanced stage III was observed in patients with the TLR9 rs187084 variant CC genotype compared to TT (P = 0.047) and to T-allele carriers (TT + CT, P = 0.037). Kaplan-Meier analysis revealed a lower overall survival (OS) rate in patients with the TLR9 rs187084 variant CC genotype compared to the TT genotype (P = 0.010, log-rank test) and to T-allele carriers (TT + CT genotypes, P = 0.002), though it was not an independent predictor of OS. Both TLR9 rs187084 and TLR7 rs3853839 polymorphisms were associated with high alcohol consumption (P = 0.027 and P = 0.001, respectively). The investigated genetic variations were not associated with OSCC susceptibility. The variant CC genotype of the TLR9 rs187084 polymorphism might be a marker of poor survival and tumor progression in OSCC.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsPolymorphism, Single NucleotideToll-Like Receptor 7Toll-Like Receptor 9AdultAgedCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedPrognosisTLR7 protein, humanTLR9 protein, humanToll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID38850110
PMCPMC11496855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.